MAPT and Alzheimer disease: Tau phosphorylation by GSK3β is associated with multiple neuropathological events during the progression of AD [37], including the formation of NFTs [40], the formation of oligomeric Aβ in neurons, and even dendritic spine loss induced by Aβ [41].